Genfit, Evogene leads healthcare gainers, Rite Aid, Cellect Biotechnology among major losers
Gainers: Genfit (GNFT) +15%, Evogene (EVGN) +13%, Marinus Pharmaceuticals (MRNS) +11%, Endo International (ENDP) +8%, Happiness Biotech Group (HAPP) +7%.Losers: Rite Aid (RAD) -10%, Cellect Biotechnology (APOP) -8%, Kaleido Biosciences (KLDO) -7%, Taiwan Liposome (TLC) -6%, Nephros (NEPH) -6%.
Seekingalpha · 5h ago
Owens & Minor, Kaleido Biosciences among major healthcare gainers, MediciNova, Rite Aid leads losers pack
Gainers: Owens & Minor (OMI) +53%, Kaleido Biosciences (KLDO) +39%, LogicBio Therapeutics (LOGC) +30%,  Cellect Biotechnology (APOP) +25%, Neuronetics (STIM) +6%.Losers: MediciNova (MNOV) -20%, Rite Aid (RAD) -17%, ADiTx Therapeutics (ADTX) -12%, NanoVibronix (NAOV) -12%, Rockwell Medical (RMTI) -10%.
Seekingalpha · 1d ago
Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the Mesa
Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business CollaborationsTel Aviv, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) --  Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology which enables the functional selection
GlobeNewswire · 4d ago
Cellect Bio nabs new patent in Europe
European Patent Office has granted Cellect Biotechnology (APOP +3.6%) a Patent Application no. 14851547.1 for Apograft, covering the activation of the stem
seekingalpha · 08/06 18:40
European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as European Patent Application
PR Newswire · 08/06 12:30
Cellect Biotechnology Q1 EPS $(0.002) Up From $(0.008) YoY
Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.00) per share. This is a 75 percent increase over losses of $(0.01) per share from the same period last year.
Benzinga · 05/21 20:19
84 Biggest Movers From Yesterday
Benzinga · 05/13 09:31
60 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 05/12 16:26
Company News for May 12, 2020
Zacks · 05/12 15:09
Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 Million
GlobeNewswire · 05/12 13:48
GNFT, DT among premarket losers
Seeking Alpha - Article · 05/12 13:19
78 Biggest Movers From Yesterday
Benzinga · 05/12 09:02
Mid-Afternoon Market Update: NASDAQ Rises Over 100 Points; Amneal Pharmaceuticals Shares Surge On Upbeat Results
Toward the end of trading Monday, the Dow traded down 0.11% to 24305.58 while the NASDAQ rose 1.17% to 9228. The S&P also rose, gaining 0.27% to 2,937.69.
Benzinga · 05/11 19:02
AMC, CYTK, MT and SALT among midday movers
Seeking Alpha - Article · 05/11 16:40
54 Stocks Moving In Monday's Mid-Day Session
Benzinga · 05/11 16:39
Mid-Day Market Update: Recro Pharma Falls After Q1 Results; MyoKardia Shares Climb
Midway through trading Monday, the Dow traded down 0.80% to 24135.84 while the NASDAQ rose 0.19% to 9138.42. The S&P also fell, dropping 0.42% to 2917.35.
Benzinga · 05/11 16:29
Why Israeli Stem Cell Therapy Company Cellect Biotech Is Rallying
Shares of nano-cap stem cell therapy company Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) were advancing strongly Monday.
Benzinga · 05/11 15:46
Mid-Morning Market Update: Markets Mostly Lower; Cardinal Health Beats Q3 Estimates
Following the market opening Monday, the Dow traded down 0.83% to 24128.74 while the NASDAQ rose 0.19% to 9,138.91. The S&P also fell, dropping 0.52% to 2,914.59.
Benzinga · 05/11 14:15
CAH, BLUE among premarket gainers
Seeking Alpha - Article · 05/11 13:26
32 Stocks Moving in Monday's Pre-Market Session
Benzinga · 05/11 11:18
Webull provides a variety of real-time APOP stock news. You can receive the latest news about Cellect Bio through multiple platforms. This information may help you make smarter investment decisions.
About APOP
Cellect Biotechnology Ltd is an Israel-based biotechnology company. Its technology platform, ApoGraft, selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies by using functional selection. Efficient selection enables retention of most of the stem cells while neutralizing harmful mature cells. ApoGraft exploit a functional characteristic of stem cells relating to apoptosis, which is the process of programmed cell death and is a vital part of physiological development and homeostasis of all organisms. Stem cells flourish in an environment where normal cells die because their main role is reconstitution of damaged tissue. The platform is being tested for clinical use in allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of hematological malignancies. Additionally, the Company is developing its first product based on its platform, the ApoTainer selection kit that utilizes FasL-coated paramagnetic beads.